Ignyta Stock Price (NASDAQ:RXDX)

Add to My Stocks
$26.95 $0 (0%) RXDX stock closing price Feb 08, 2018 (Closing)
Prev Close* : $26.95
Market Cap:
Day Low: $0
52 Week Low: $5.70
Open: $0
Volume: -
Day High: $0
52 Week High: $27.10

Latest Stock Market News

Latest Articles

Ignyta News - From Partners

Company News For Dec 26, 2017 by Zacks on Dec 26, 2017

Last Analytics

market capitalization of berkshire hathaway mobil exxon stock price berkshire hathaway nyse indu stock chart hsy stock split active stock ticker banco santander sa dividend berkshire hathaway stock b price ny stock exchange companies berkshire stock quote stock market dow jones chart brka stock quote hsy stock split

RXDX Stockcharts

View RXDX PE ratio, PS ratio stocks charts and compare with peers.
Note: Compare Ignyta stock price history with the index and industry peers.

Ignyta Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Ignyta Returns

(return on equity)

Ignyta Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

RXDX Industry Peers

Company Price Change (%)
Portola Pharma (PTLA)27.550.62 (2.2%)
Tesaro Inc (TSRO)37.690.12 (0.32%)
Stemline Therapeutics (STML)17.30.3 (1.76%)
Blueprint Medicines (BPMC)69.612.01 (2.81%)
Endocyte (ECYT)17.530.1 (0.57%)
Eli Lilly (LLY)106.330.26 (0.25%)
Pfizer (PFE)44.060.31 (0.71%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
SIGA Technologies (SIGA)7.230.48 (7.11%)
AcelRx Pharma (ACRX)3.950.25 (6.76%)
ChemoCentryx (CCXI)12.910.54 (4.37%)
Infinity Pharma (INFI)2.40.09 (3.9%)
Redhill Biopharma (RDHL)8.040.14 (1.77%)
Adamis Pharma (ADMP)3.10.05 (1.64%)
BioSpecifics Technologies (BSTC)58.520.78 (1.35%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Lannett Co (LCI)50.5 (9.09%)
Neptune Tech. & Bio. (NEPT)4.340.38 (8.05%)
Tetraphase Pharmaceuticals (TTPH)2.920.24 (7.59%)
CORREVIO PHARMA (CORV)4.020.27 (6.29%)
Arrowhead Pharma (ARWR)17.771.11 (5.88%)
Galectin Therapeutics (GALT)6.530.4 (5.77%)
Esperion Therapeutics (ESPR)43.162.59 (5.66%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

Ignyta Inc Stock News - Partner Headlines

Ignyta Financial Statements

income statement20162015201420132012
Net Sales or Revenues-----
Net Income-103.63M-92.45M-39.98M-14.21M-1.27M
Total Operating Expense100.67M90.57M39.99M13.9M0
View Ignyta income statement
balance sheet20162015201420132012
Total Assets144.91M196.14M85.3M53.31M5.44M
Total Liabilities50.14M60.16M29.35M11.53M-
Shareholders Equity94.77M135.98M55.94M41.78M4.56M
View Ignyta balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-7.08M3.43M--
Net Cash from (used by) Operating Activities-90.11M-50.8M-32.48M-13.07M-0.99M
Increase (Decrease) in Prop Plant And Equipment-2.37M-3.52M-3.1M-0.67M-0.3M
View Ignyta cash flow statement

Ignyta Stock Message Board

Ignyta stock lost 0%, and the last close price as of Feb 08, 2018 is $26.95 for RXDX stock. Ignyta market capitalization is $1.82B and it represents the total market value of RXDX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Ignyta stock analysis.

The terms stocks and shares mean the same thing. For Ex: Ignyta stock price and Ignyta share price mean the same thing. The volume of shares traded stood at 254,655 on the last trading day, as is evident from Ignyta stock chart, and RXDX stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Ignyta stock dividend was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Ignyta stock price history.